Skip to content

Our Science
Therapeutic Areas
About Us
Publications
Media
Contact
Investors

Home
Our Science
Therapeutic Areas
About NeuroScientific

Investors

ASX Announcements
Annual Reports
Publications
Contact
Media

Our Science
Therapeutic Areas
About Us
Publications
Media
Contact
Investors

Home
Our Science
Therapeutic Areas
About NeuroScientific

Investors

ASX Announcements
Annual Reports
Publications
Contact
Media

Month: September 2022

September, 2022

Investor Update from NSB Chairman Paul Rennie

September, 2022

NeuroScientific Biopharmaceuticals Investor Update Webinar

Search

Recent Posts

Investor Update from NSB Chairman Paul Rennie
NeuroScientific Biopharmaceuticals Investor Update Webinar
NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”
Broker Briefing Webinar with Dr Alexandra Andrews
Investor Webinar Presentation ShareCafe Small Cap “Hidden Gems” Webinar

Recent Comments

Archives

September 2022
December 2021
November 2021
September 2021
August 2021
July 2021
June 2021
October 2019
July 2019
June 2019
December 2018
November 2018
June 2018
April 2018

Categories

EmtinB
Glaucoma
LRP1
Metallothionein
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Subscribe for important NeuroScientific announcements and updates

Email Address:

Leave this field empty if you're human:

NeuroScientific

Our Science
Therapeutic Areas
About Us
Publications
Media

Investors

ASX Announcements
Annual Reports
Corporate Governance

Contact Us

NeuroScientific Biopharmaceuticals Ltd
Suite 5, 85 Forrest St
Cottesloe WA 6011
info@neuroscientific.com

© 2019 NeuroScientific Biopharmaceuticals Ltd. ACN 102 832 995 /
Site by Super Minimal